RESUMEN
Aloe vera gel is widely used in the treatment of an array of disturbances, especially skin disorders. The wound-healing effects have been attributed to its moisturizing and anti-inflammatory effects as well as its beneficial effect on the maturation of collagen. The aim of the present study is to compare the effects of topically applied extracts of Aloe ferox with that of Aloe vera on the symptoms as well as IgE levels of a mouse model of atopic dermatitis (AD). Mice were sensitized and challenged with 2,4-dinitrochlorobenzene and treated afterwards for 10 consecutive days with the gels of either A. ferox or A. vera applied topically to the affected areas. A placebo gel was used for the control mice. Blood was collected at the beginning and end of the treatment period to measure serum IgE levels. Although the gels of both the Aloe species inhibited the cutaneous inflammatory response as well as serum IgE levels in the rats, the extracts of A. ferox were superior to that of A. vera in reducing IgE levels. The gels of A. ferox and A. vera, applied topically, may be a safe and useful alternative to antihistamines and topical corticosteroids, for the treatment of patients suffering from recurring chronic AD.
Asunto(s)
Dermatitis Atópica/tratamiento farmacológico , Geles/farmacología , Extractos Vegetales/farmacología , Hojas de la Planta/química , Administración Cutánea , Administración Tópica , Aloe , Animales , Antiinflamatorios/química , Antiinflamatorios/inmunología , Antiinflamatorios/farmacología , Dermatitis Atópica/inmunología , Modelos Animales de Enfermedad , Método Doble Ciego , Geles/química , Inmunoglobulina E/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Fitoterapia/métodos , Extractos Vegetales/química , Extractos Vegetales/inmunología , Hojas de la Planta/inmunología , Piel/efectos de los fármacos , Piel/inmunología , Cicatrización de Heridas/efectos de los fármacos , Cicatrización de Heridas/inmunologíaRESUMEN
OBJECTIVES: The effects of two humate products were compared to that of prednisolone on a contact hypersensitivity rat model. METHODS: Rats, sensitized with dinitrofluorobenzene (DNFB), were placed on a daily oral treatment of 61 mg/kg BW of humate derived from either leonardite or bituminous coal or on prednisolone at one mg/kg BW and challenged 6 days later with a topical application of DNFB to the right ear. The inflamed ears were measured daily. In a toxicity study rats were exposed to daily oral treatment of leonardite humate at 1,000 mg/kg BW for 1 month. A teratogenicity study was done where pregnant rats were treated with 500 mg/kg BW on days 5 to 17 of pregnancy. RESULTS: Only the leonardite humate compared favourably with prednisolone in suppressing contact hypersensitivity. No signs of toxicity were observed and weight gain was normal during the 6-day and 1 month treatments and during the teratogenicity study with the leonardite humate. However, the rats on the other two products experienced slower weight gain. CONCLUSION: The identification of a naturally occurring nontoxic compound with anti-inflammatory activity is exciting and merits further evaluation in the treatment of patients suffering from inflammatory conditions.
Asunto(s)
Antiinflamatorios/farmacología , Carbón Mineral , Dermatitis por Contacto/prevención & control , Sustancias Húmicas , Anomalías Inducidas por Medicamentos/etiología , Administración Oral , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/toxicidad , Peso Corporal/efectos de los fármacos , Dermatitis por Contacto/etiología , Dinitrofluorobenceno , Modelos Animales de Enfermedad , Femenino , Feto/efectos de los fármacos , Sustancias Húmicas/toxicidad , Prednisolona/farmacología , Embarazo , Ratas , Ratas Sprague-Dawley , Factores de TiempoRESUMEN
Irinotecan and its metabolite SN38 were evaluated for their cytotoxicity and influence on radiosensitivity in WHO3 human oesophageal cells under hypoxic conditions. The IC50's of Irinotecan and SN-38 were found to be 0.8 and 0.04 microM, repectively, with SN-38 emerging as the more potent drug. The toxicities were similar under anoxic conditions. Given in conjunction with irradiation under hypoxic conditions, the two drugs restored the radiosensitivity of WHO3 cells in a dose-dependent manner by factors of 1.5-2.1 as compared to a control oxygen enhancement ratio (OER) of 2.1 in this cell system. In the subtoxic concentration range of 10(-2) microM SN-38 still generated a marked sensitisation of hypoxic tumour cells by factors of 1.2-1.6. It is concluded that the topoisomerase inhibitor Irinotecan and in particular the metabolite SN-38 may be clinically useful for radiotherapy of notoriously hypoxic tumour pathologies.
Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Camptotecina/análogos & derivados , Neoplasias Esofágicas/tratamiento farmacológico , Neoplasias Esofágicas/radioterapia , Fármacos Sensibilizantes a Radiaciones/farmacología , Camptotecina/farmacología , Hipoxia de la Célula , Línea Celular Tumoral , Terapia Combinada , Neoplasias Esofágicas/metabolismo , Humanos , IrinotecánRESUMEN
The in vitro affinity and adsorption capacity of a humic acid, oxihumate, for aflatoxin B1 (AFB1) was evaluated, utilizing Langmuir and Freundlich adsorption isotherms. Oxihumate showed a high in vitro affinity for AFB1. The Freundlich isotherm fitted the data better than the Langmuir isotherm, and binding capacities of 10.3, 7.4, and 11.9 mg of AFB1/g of oxihumate at pH 3, 5, and 7, respectively, were calculated. The in vivo efficacy of oxihumate as an aflatoxin binder in male broiler chickens exposed to aflatoxin-contaminated feed from 7 to 42 d of age was also assessed. The efficacy of oxihumate was compared with a commercially available product with a brewers dried yeast (BDY) and brewers fermentation solubles as main active ingredients. A total of 420 birds were assigned to 28 pens, with 15 birds per pen. The following treatments were applied: 1) 0 mg of AFB1 + 0 additives, 2) 1 mg of AFB1/kg of feed + 0 additives, 3) 1 mg of AFB1/kg of feed + 3.5 g of oxihumate/kg of feed, 4) 1 mg of AFB1/kg of feed + 3.5 g of BDY/kg of feed, 5) 2 mg of AFB1/kg of feed + 0 additives, 6) 2 mg of AFB1/kg of feed + 3.5 g of oxihumate/kg of feed, and 7) 2 mg of AFB1/kg of feed + 3.5 g of BDY/kg of feed. Each treatment consisted of 4 replicates. Oxihumate was effective in diminishing the adverse effects caused by aflatoxin on BW of broilers (P < 0.05). Oxihumate also showed protective effects against liver damage, stomach and heart enlargement, as well as some of the hematological and serum biochemical changes associated with aflatoxin toxicity (P < 0.05). Results indicated that oxihumate, but not BDY, could alleviate some of the toxic effects of aflatoxin in growing broilers. Oxihumate might, therefore, prove to be beneficial in the management of aflatoxin-contaminated feedstuffs for poultry when used in combination with other mycotoxin management practices. Additional studies are warranted to assess its efficacy under a wide variety of circumstances.
Asunto(s)
Aflatoxina B1/química , Aflatoxina B1/toxicidad , Alimentación Animal , Pollos/metabolismo , Sustancias Húmicas , Micotoxicosis/veterinaria , Enfermedades de las Aves de Corral/inducido químicamente , Adsorción , Aflatoxina B1/metabolismo , Alimentación Animal/análisis , Animales , Relación Dosis-Respuesta a Droga , Sustancias Húmicas/análisis , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Micotoxicosis/prevención & control , Enfermedades de las Aves de Corral/prevención & control , Aumento de Peso/efectos de los fármacosRESUMEN
Clofazimine, a riminophenazine antimicrobial agent, and its analogue B669 were investigated for their effects on FaDu cells, a human squamous carcinoma cell line. These agents, at concentrations within the therapeutic range (0.25-2 micrograms/ml), caused a dose-dependent tumor cell cytotoxicosis which was greatly enhanced in the presence of human neutrophils. The neutrophil-mediated increment in tumoricidal activity, but not the direct antitumor effects of the drugs per se, was inhibited by catalase. The effects of these drugs on three more cell carcinoma lines as well as on two primary cultures and a noncarcinoma cell line were also investigated and compared with the activity of the standard antitumor chemotherapeutic agents bleomycin, cisplatin, and methotrexate. All seven cultures were sensitive to clofazimine and B669 compared to six that were sensitive to cisplatin, three that were sensitive to bleomycin, and one that was sensitive to methotrexate. The treatment of FaDu cells with clofazimine and B669 was associated with enhanced activity of phospholipase A2, as evidenced by increased release of radiolabeled arachidonate and lysophosphatidylcholine from membrane phospholipids. Inhibitors of arachidonic acid metabolism, protein kinase C inhibitors, as well as water and lipid soluble antioxidants failed to protect the cells against the cytotoxic activity of clofazimine and B669. However, alpha-tocopherol, a lysophospholipid-complexing agent, completely blocked the antiproliferative effects of the riminophenazines and also protected the cells against the direct cytotoxic effect of lysophosphatidylcholine, while the lysophospholipid-neutralizing enzyme lysophospholipase protected against the riminophenazines. These observations demonstrate that the tumoricidal properties of clofazimine and B669 are probably due to increases in the lysophospholipid content of cell membranes.
Asunto(s)
Clofazimina/análogos & derivados , Inhibidores de Crecimiento , Animales , Ácido Araquidónico/metabolismo , Bleomicina/farmacología , Muerte Celular , División Celular/efectos de los fármacos , Cisplatino/farmacología , Clofazimina/farmacología , Inhibidores de la Ciclooxigenasa/farmacología , Citotoxicidad Inmunológica , Humanos , Técnicas In Vitro , L-Lactato Deshidrogenasa/metabolismo , Inhibidores de la Lipooxigenasa/farmacología , Lisofosfatidilcolinas/metabolismo , Metotrexato/farmacología , Neutrófilos/fisiología , Oxidación-Reducción , Fosfolipasas A/metabolismo , Fosfolipasas A2 , Proteína Quinasa C/antagonistas & inhibidores , Células Tumorales Cultivadas , Vitamina E/metabolismoRESUMEN
Naphthoquinones and triterpenes isolated from the roots of Euclea natalensis. A.DC (Ebenaceae) were evaluated for their inhibitory activity against Mycobacterium tuberculosis.. Crude extract, diospyrin and 7-methyljuglone isolated from the plant, exhibited minimum inhibitory concentrations of 8.0, 8.0, and 0.5 µg ml-1, respectively, against M. tuberculosis. H37 Rv (ATCC 27294), a drug-sensitive strain. Minimum inhibitory concentrations (MICs) of 7- methyljuglone against a panel of clinical pan-sensitive and drug-resistant strains of M. tuberculosis. ranged from 0.32 to 1.25 µg/ml. The concentration of 7-methyljuglone that effected a 90% reduction of growth of M. tuberculosis. Erdman within J774.1 macrophages was 0.57 µg/ml. The superior intracellular and extracellular inhibition of M. tuberculosis. by 7-methyljuglone relative to that of the antituberculosis drugs streptomycin and ethambutol suggests that this compound be considered as a lead for further investigations.
RESUMEN
The effects of the phagocyte-derived reactive oxidants hydrogen peroxide (H2O2) and hypochlorous acid (HOC1) on the activity of poly(ADP-ribose) polymerase (pADP RP), an enzyme involved in DNA repair, and on the induction and repair of DNA strand breaks in human mononuclear leukocytes (MNL) have been investigated in vitro. Exposure of MNL to reagent H2O2 was accompanied by DNA damage and activation of pADP RP. Addition of reagent HOCl (25 microM) was not associated with DNA strand breaks. However, when combined with 150 microM H2O2, HOCl potentiated H2O2-mediated DNA damage, and compromised the repair process. Furthermore, HOCl caused a dose-related decrease in the activity of pADP RP in both control and H2O2-exposed MNL. Interactions between the phagocyte-derived reactive oxidants H2O2 and HOCl are probably involved in the etiology of inflammation-related cancer.
Asunto(s)
Ácido Hipocloroso/farmacología , Inhibidores de Poli(ADP-Ribosa) Polimerasas , Adulto , Daño del ADN/efectos de los fármacos , ADN de Cadena Simple/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Radicales Libres , Humanos , Peróxido de Hidrógeno/farmacología , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/enzimología , Neutrófilos/efectos de los fármacos , Neutrófilos/enzimología , Poli(ADP-Ribosa) Polimerasas/sangre , Poli(ADP-Ribosa) Polimerasas/efectos de los fármacosRESUMEN
Differential expression of a permeability glycoprotein (P-gp) in human myeloleukaemia K562 cells grown in the presence of the anti-cancer drug, doxorubicin, gave rise to subclones with varying degrees of resistance to other anti-tumour drugs such as vinblastine and daunorubicin. Subclones K562/MMB, MMG and MMF were produced from the parental (K562/P) cell line via limiting dilution and their MDR nature confirmed with flow cytometry using an MRK 16 monoclonal antibody directed at a surface epitope of the P-gp pump. The pattern of increasing P-gp expression in the series K562/P, MMF, MMG and MMB was paralleled by increasing resistance to vinblastine and daunorubicin. When the subclones were pre-incubated with the chemosensitizing drugs clofazimine and B669, a pattern of increasing reversal of resistance to vinblastine and daunorubicin was seen in the series K562/P, MMF, MMG and MMB.
Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Clofazimina/análogos & derivados , Clofazimina/farmacología , Leucemia Eritroblástica Aguda/tratamiento farmacológico , Leucemia Eritroblástica Aguda/metabolismo , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/biosíntesis , Antineoplásicos/farmacología , Antineoplásicos Fitogénicos/farmacocinética , Interacciones Farmacológicas , Resistencia a Múltiples Medicamentos , Ensayos de Selección de Medicamentos Antitumorales , Ácido Etacrínico/farmacología , Citometría de Flujo , Genisteína , Humanos , Isoflavonas/farmacología , Tritio , Células Tumorales Cultivadas/efectos de los fármacos , Vinblastina/farmacocinéticaRESUMEN
The effects of the membrane-stabilizing agent, alpha-tocopherol (25 microg/ml), on the chemosensitizing interactions of cyclosporin A (5 microg/ml), verapamil (2 microg/ml), clofazimine (1 microg/ml), B669 (0.5 microg/ml) and GF120918 (0.015 microg/ml) with a P-glycoprotein-expressing human lung cancer cell line (H69/LX4) have been investigated in vitro. In an assay of cell proliferation, all the chemosensitizing agents restored the sensitivity of H69/LX4 cells to doxorubicin and vinblastine. The inclusion of alpha-tocopherol (25 microg/ml) antagonized the multidrug-resistance (MDR)-modifying activity of all five chemosensitizing agents, effectively preventing restoration of sensitivity to both doxorubicin and vinblastine in H69/LX4 cells.
Asunto(s)
Resistencia a Múltiples Medicamentos , Neoplasias Pulmonares/tratamiento farmacológico , Tetrahidroisoquinolinas , Vitamina E/farmacología , Acridinas/farmacología , Muerte Celular , Clofazimina/análogos & derivados , Clofazimina/farmacología , Ciclosporina/farmacología , Humanos , Isoquinolinas/farmacología , Neoplasias Pulmonares/metabolismo , Células Tumorales Cultivadas , Verapamilo/farmacología , Vinblastina/metabolismoRESUMEN
The potential of the riminophenazine agents clofazimine and B669, at therapeutically relevant concentrations, to reverse P-glycoprotein-mediated multidrug-resistance (MDR) in a human lung cancer cell line (H69/LX4) has been investigated in vitro. Cyclosporin A, a well-documented MDR-modifying agent, was included for comparison. Clofazimine, B669 and cyclosporin A at minimally cytotoxic concentrations of 1, 0.5 and 5 micrograms/ml, respectively, were equally effective in restoring sensitivity to vinblastine, doxorubicin, daunorubicin and mitomycin C in the H69/LX4 cell line. All three chemosensitizing agents also increased the accumulation of [14C]vinblastine by H69/LX4 cells. Riminophenazines, which are relatively non-toxic, non-carcinogenic and non-myelosuppressive agents, are promising contenders for evaluation in experimental and clinical oncology as modulators of acquired MDR.
Asunto(s)
Antiinfecciosos/farmacología , Antineoplásicos/farmacología , Carcinoma de Células Pequeñas/tratamiento farmacológico , Clofazimina/análogos & derivados , Clofazimina/farmacología , Resistencia a Múltiples Medicamentos , Neoplasias Pulmonares/tratamiento farmacológico , Antineoplásicos/farmacocinética , Radioisótopos de Carbono , Carcinoma de Células Pequeñas/metabolismo , División Celular/efectos de los fármacos , Ciclosporina/farmacología , Interacciones Farmacológicas , Humanos , Neoplasias Pulmonares/metabolismo , Células Tumorales Cultivadas , Vinblastina/farmacocinética , Vinblastina/farmacologíaRESUMEN
The lipophilicity and membrane-destabilizing activities of clofazimine and three tetramethyl-piperidine (TMP)-substituted phenazines were compared with the anti-tumor and multiple drug resistance (MDR) neutralizing potential of these agents using a P-glycoprotein (P-gp)-expressing small cell lung cancer cell line (H69/LX4). Partition coefficients were measured as an index of lipophilicity, while membrane-destabilizing potential was measured using a conventional hemolytic assay. The membrane-destabilizing potential of the TMP-substituted phenazines was found to correlate positively with the degree of lipophilicity, as well as with MDR reversal activity. The presence of a TMP group, as well as chlorine atoms on the phenyl and anilino rings of these agents contributed to the enhancement of anti-tumor activity by potentiating membrane-destabilizing activity. TMP-substituted phenazines may be useful in the design of novel anti-cancer and MDR reversal agents.
Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Membrana Celular/efectos de los fármacos , Clofazimina/farmacología , Células Tumorales Cultivadas/efectos de los fármacos , Benzotiazoles , Carcinoma de Células Pequeñas/tratamiento farmacológico , Carcinoma de Células Pequeñas/metabolismo , Supervivencia Celular/efectos de los fármacos , Clofazimina/análogos & derivados , Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Citometría de Flujo , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/metabolismo , Fluidez de la Membrana/efectos de los fármacos , Quinolinas , Relación Estructura-Actividad , Tiazoles/metabolismo , Células Tumorales Cultivadas/metabolismo , Vinblastina/farmacologíaRESUMEN
The effect of the O2-dependent antimicrobial systems of the human neutrophil on the intraphagocytic activity of difloxacin, ciprofloxacin, pefloxacin and fleroxacin was determined by use of a radioassay with Staphylococcus aureus as the test organism. The fluoroquinolones exhibited good intraphagocytic activity with normal neutrophils. However the intracellular bioactivities of the four antimicrobial agents were substantially less in tests with neutrophils from two patients with chronic granulomatous disease. These observations suggest a synergic interaction between fluoroquinolones and the O2-dependent antimicrobial systems of phagocytes in the eradication of intracellular microbial pathogens.
Asunto(s)
Antiinfecciosos , Ciprofloxacina/análogos & derivados , Ciprofloxacina/farmacología , Fluoroquinolonas , Neutrófilos/fisiología , Pefloxacina/farmacología , Fagocitosis , Staphylococcus aureus/efectos de los fármacos , Niño , Preescolar , Fleroxacino , Enfermedad Granulomatosa Crónica/metabolismo , Humanos , Staphylococcus aureus/crecimiento & desarrolloRESUMEN
SETTING: Inflammation-related oxidative stress has been implicated in the pathogenesis of lung fibrosis and dysfunction in patients with pulmonary tuberculosis. OBJECTIVE: To investigate the effects of antimicrobial chemotherapy and smoking status on the plasma concentrations of the anti-oxidative nutrients vitamin C, vitamin E and beta-carotene, as well as those of iron, lipid peroxides and the acute phase reactants C-reactive protein (CRP) and ferritin. DESIGN: A total of 41 patients with active pulmonary tuberculosis were studied at the outset and after 6 months of antimicrobial chemotherapy. RESULTS: Initial plasma concentrations of vitamin C and beta-carotene were low, returning to normal values after chemotherapy in the non-smokers, but not in the smokers, while those of vitamin E remained low throughout in both groups. Ferritin and CRP concentrations decreased significantly following chemotherapy, with the former higher in smokers than in non-smokers. Serum lipid peroxides were elevated in patients with pulmonary tuberculosis and were unaffected by chemotherapy or smoking habits, while iron levels were not significantly affected by chemotherapy. Although residual dysfunction and infiltration were evident, pulmonary function (FEV1) and radiographic score improved equally in both smokers and non-smokers following antimicrobial chemotherapy. CONCLUSIONS: Even after 6 months of apparently successful antimicrobial chemotherapy, pulmonary tuberculosis is associated with increased oxidative stress, which is unrelated to cigarette smoking and characterized by increased levels of circulating lipid peroxides and low concentrations of plasma vitamin E.
Asunto(s)
Antioxidantes/metabolismo , Estrés Oxidativo , Tuberculosis Pulmonar/sangre , Tuberculosis Pulmonar/tratamiento farmacológico , Proteínas de Fase Aguda/análisis , Adulto , Antituberculosos/uso terapéutico , Ácido Ascórbico/sangre , Femenino , Humanos , Hierro/sangre , Peróxidos Lipídicos/sangre , Masculino , Persona de Mediana Edad , Pruebas de Función Respiratoria , Fumar/sangre , Fumar/fisiopatología , Tuberculosis Pulmonar/fisiopatología , Vitamina E/sangre , beta Caroteno/sangreRESUMEN
The potential of B4121 to sensitize three intrinsically resistant human colon cancer cell lines (CaCo2, ATCC HTB 37; COLO 32 DM, ATCC CCL 220; HT-29, ATCC HTB 38) to vinblastine, doxorubicin, daunorubicin, paclitaxel, taxotere and cisplatin at a non-toxic, therapeutically relevant concentration of 0.25 microg/ml was compared with that of clofazimine at a similar concentration. The cell line expressing high levels of P-glycoprotein (P-gp), COLO 320 DM, was susceptible to chemosensitization by the experimental agents for the P-gp substrates (paclitaxel, taxotere, daunorubicin, vinblastine and doxorubicin) but not for cisplatin. CaCo2 cells expressed lower levels of P-gp and were only marginally susceptible to sensitization by any one of these drugs, except in the case of sensitization by B4121 for doxorubicin and taxotere, whereas the HT-29, a P-gp negative cell line, was unaffected. The riminophenazines, especially B4121, might prove useful as combination treatment in circumventing P-gp mediated resistance of colon cancers.
Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/análisis , Clofazimina/análogos & derivados , Clofazimina/farmacología , Neoplasias del Colon/tratamiento farmacológico , Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Citometría de Flujo , Humanos , Células Tumorales CultivadasRESUMEN
GF120918, at 250 ng/ml, increased the sensitivity of a P-glycoprotein (P-gp)-mediated multidrug resistant (MDR) small cell lung cancer cell line (H69/LX4) to the P-gp substrates, paclitaxel, taxotere, vinblastine, vinorelbine, daunorubicin and etoposide to levels which were either greater (in the case of etoposide) or close to that of the parent cell line (H69/P). This was achieved in spite of the great variation in the levels of resistance of the MDR cell line for the various anti-cancer drugs tested. These data suggest that GF120918 is a potent antagonist of P-gp mediated multidrug resistance, even in the case of high levels of resistance, as was the case with paclitaxel and taxotere (2560 and 2215 fold more than the sensitive parent cell line respectively).
Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/fisiología , Acridinas/farmacología , Carcinoma de Células Pequeñas/patología , Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Isoquinolinas/farmacología , Neoplasias Pulmonares/patología , Proteínas de Neoplasias/fisiología , Taxoides , Tetrahidroisoquinolinas , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/antagonistas & inhibidores , Acridinas/química , Carcinoma de Células Pequeñas/metabolismo , División Celular/efectos de los fármacos , Daunorrubicina/farmacología , Docetaxel , Etopósido/farmacología , Humanos , Isoquinolinas/química , Neoplasias Pulmonares/metabolismo , Estructura Molecular , Proteínas de Neoplasias/antagonistas & inhibidores , Paclitaxel/análogos & derivados , Paclitaxel/farmacología , Células Tumorales Cultivadas/efectos de los fármacos , Vinblastina/análogos & derivados , Vinblastina/farmacología , VinorelbinaRESUMEN
BACKGROUND: Determination of the drug concentration required to kill 50% of the tumour cells (EC50) does not take into account the propensity of cells to undergo apoptosis and necrosis. These 2 parameters and the viable cells are here assessed by a flow cytometric (FC) approach using propidium iodide (PI) and FITC-Annexin V staining. MATERIALS AND METHODS: A number of carcinoma cell lines of defined p53 status were exposed to cis-PtII for 24 hours, stained with PI and FITC-Annexin V and analyzed by FC. Unstained viable cells, early apoptotic cells and necrotic cells were scored separately in dual parameter plots of green fluorescence (FITC) against red fluorescence (PI) to generate dose response curves. RESULTS: EC50 values for cell viability were found to be 1-4 times higher than survival data from colony assays resembling data obtained by MTT or Crystal Violet vital dye staining. Percentage apoptosis measured by Annexin V binding was in agreement with microscopic scoring of apoptotic cells after Acridine Orange staining. CONCLUSION: The FC assay described gives a good estimate of cell viability resembling data from vital dye staining assays and provides additional information on apoptosis and necrosis. FC data from Annexin V binding and microscopic scoring after Acridine Orange staining were in excellent agreement.
Asunto(s)
Antineoplásicos/farmacología , Ensayos de Selección de Medicamentos Antitumorales/métodos , Citometría de Flujo/métodos , Apoptosis/efectos de los fármacos , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/patología , Supervivencia Celular/efectos de los fármacos , Humanos , Masculino , Neoplasias de la Próstata/tratamiento farmacológico , Neoplasias de la Próstata/patología , Células Tumorales CultivadasRESUMEN
Dithranol at therapeutic concentrations (5-40 micrograms ml-1) induced strand breaks in human leucocyte DNA in vitro in a dose-related manner. Leucocytes from individuals with chronic granulomatous disease (CGD) incurred substantially less DNA strand breaks than did normal leucocytes during exposure to dithranol indicating that activated phagocytes are involved. H-7, 4-beta-bromophenacyl bromide (BPB) and staurosporine, all inhibitors of protein kinase C, decreased both dithranol-mediated activation of the phagocyte respiratory burst and induction of DNA strand breaks. Similar effects were observed with the hydrogen peroxide scavenger catalase. These results suggest that dithranol induces DNA strand breaks, mainly as a result of pro-oxidative interactions with phagocytes.
Asunto(s)
Antralina/toxicidad , Daño del ADN , Leucocitos/metabolismo , Fagocitos/metabolismo , Acetofenonas/farmacología , Alcaloides/farmacología , Catalasa/metabolismo , Enfermedad Granulomatosa Crónica/genética , Humanos , Leucocitos/efectos de los fármacos , Mediciones Luminiscentes , Oxidación-Reducción , Consumo de Oxígeno/efectos de los fármacos , Proteína Quinasa C/antagonistas & inhibidores , EstaurosporinaRESUMEN
The protective effects of physiological concentrations (3-12.5 micrograms/ml) of vitamin E (VE, dl-alpha-tocopherol) on the formation of DNA single-strand breaks in mononuclear leukocytes (MNL) in close proximity to activated phagocytes have been investigated in vitro. Human neutrophils, activated by phorbol myristate acetate (PMA), induced DNA-strand breaks in neighbouring lymphocytes. Vitamin E caused dose-related protection of MNL DNA against phagocyte-mediated oxidative damage. This apparently novel protective activity of vitamin E is due primarily to the inhibitory effects of this agent on the generation of reactive oxidants by activated neutrophils and is apparently unrelated to the classical oxidant-scavenging properties of VE.
Asunto(s)
Daño del ADN/efectos de los fármacos , Peróxido de Hidrógeno/toxicidad , Leucocitos Mononucleares/efectos de los fármacos , Neutrófilos/metabolismo , Vitamina E/farmacología , Adulto , Humanos , Leucocitos Mononucleares/metabolismo , NADH NADPH Oxidorreductasas/antagonistas & inhibidores , NADPH Oxidasas , Superóxidos/metabolismo , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
In this study the formation of DNA single-strand breaks in MNL in close proximity to activated phagocytes, or in contact with added H2O2 and/or HOCl, were evaluated. Neutrophils activated by phorbol myristate acetate (PMA), induced DNA-strand breaks in neighboring lymphocytes which increased after 1-2 h incubation in a repair medium. These DNA-strand breaks could be prevented by the addition of catalase or substitution of the neutrophils with cells from a patient with chronic granulomatous disease. Inclusion of the myeloperoxidase (MPO) inhibitor, sodium azide (NaN3), to the system was associated with less damage after 1-2 h incubation and a faster repair rate. Exposure of MNL to added reagent H2O2 (12-100 microM) was also accompanied by DNA damage. Addition of reagent HOCl (3-25 microM) did not induce any DNA-strand breaks. However, when combined with H2O2 (12.5 microM), HOCl increased H2O2-mediated DNA damage and compromised the repair process. Interactions between the phagocyte-derived reactive oxidants H2O2 and HOCl are probably involved in the etiology of inflammation-related cancer.
Asunto(s)
Daño del ADN , Peróxido de Hidrógeno/toxicidad , Ácido Hipocloroso/farmacología , Leucocitos Mononucleares/efectos de los fármacos , Adulto , Sinergismo Farmacológico , Humanos , Técnicas In Vitro , Cinética , Pruebas de Mutagenicidad , Neutrófilos/inmunologíaRESUMEN
In this study the frequencies of sister-chromatid exchanges (SCEs) were correlated with measurements of the release of reactive oxidants by phagocytes, as determined by luminol-enhanced chemiluminescence (LECL), and levels of the anti-oxidants ascorbate, beta-carotene and vitamin E in blood specimens taken from 65 young asymptomatic cigarette smokers. Increased SCE frequencies correlated with LECL responses (p less than 0.0075) of activated blood phagocytes. Anti-oxidant levels did not correlate with either LECL or SCEs. These findings indicate that increased generation of reactive oxidants by circulating phagocytes from cigarette smokers are associated with cytogenetic changes.